Today: 20 May 2026
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings
23 January 2026
1 min read

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

New York, Jan 23, 2026, 11:08 EST — Regular session

  • Shares of Thermo Fisher slipped roughly 1.2% in late morning trading, snapping a two-day winning streak
  • Investors turn their attention to the Jan. 29 results and insights on 2026 demand
  • Shares of life-science tools peers are also down

Shares of Thermo Fisher Scientific dipped on Friday as investors pared back their holdings ahead of the company’s quarterly earnings release next week, following gains earlier in the week.

The laboratory equipment and services sector often signals biotech and pharma spending patterns. With earnings just around the corner, traders are adjusting expectations for any change in management’s outlook on order trends, pricing, and margins.

Thermo Fisher shares slipped roughly 1.2% to $631.70 in late morning trading, following Thursday’s close at $639.45.

Thermo Fisher’s shares climbed about 3% since closing on Jan. 20, tightening the margin for mistakes ahead of earnings.

Thermo Fisher plans to report its fourth-quarter and full-year 2025 earnings before markets open on Thursday, Jan. 29. The company will follow up with a conference call at 8:30 a.m. ET.

A minor corporate filing caught investors’ attention this week. Dated Jan. 21, a Form 25-NSE details the removal from listing and registration of securities that have matured, been redeemed, or retired — a step linked to debt securities, not the company’s common stock.

Peers dragged the group lower as well. Danaher dropped around 1.6%, and Agilent Technologies slipped close to 1.7%. The Health Care Select Sector SPDR ETF lost about 0.5%.

According to Zacks, Wall Street anticipates earnings growth when Thermo Fisher reports next week, raising the stakes on any earnings shortfall or conservative guidance.

Investors are zeroing in on segment-level cues, especially specialty diagnostics, where forecasts expect steady demand instead of a quick bounce back.

But the setup can backfire. If management flags weaker customer spending, shrinking research budgets, or uneven instrument demand, a stock that’s already climbed ahead of the earnings report can quickly lose ground.

Thermo Fisher’s next big moment hits Thursday with its report and the 8:30 a.m. ET call on Jan. 29. Investors will be focused on guidance and order updates, which should set the tone for TMO shares going forward.

Stock Market Today

  • Minnesota First State to Ban Prediction Markets, Faces Federal Lawsuit
    May 19, 2026, 9:51 PM EDT. Minnesota has become the first U.S. state to officially ban prediction markets, platforms where users bet on event outcomes. This move follows debates in at least 14 other states on how to regulate these online markets, which blend financial speculation with forecasting. The federal government has filed a lawsuit against Minnesota's new law, challenging its prohibition. Prediction markets are viewed by supporters as effective forecasting tools but face legal scrutiny over gambling concerns. Minnesota's ban marks a significant development in the ongoing regulatory landscape for emerging digital betting and financial products.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears
Previous Story

Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT
Next Story

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Go toTop